Featured
Last news
Enable Me Finds Improved Clinic Workflow, Patient Safety and Help with Staff Shortages are Among the Benefits of the Clinically Designed VELA Mammography Chair, Per an Informal Survey of Clinicians
The cost/benefit implications of applying the VELA Chair as an extension of the clinical team and a time saver point to a clear return on investment in the short term."For the patients who need it, it has absolutely streamlined and improved the workflow. I no longer need to have a second tech in the room to assist patients who are unstable on their feet or unable to stand."
Firstleaf Introduces New Holiday Wine Offerings Featuring Curated Bundles for Every Celebration
Firstleaf, the most personalized wine company in America, is ringing in the holiday season with a new selection of exclusive wine bundles designed to elevate festive gatherings and gift giving. Expertly curated by Firstleaf's wine team, these bundles feature wines from around the world and offer something special for every celebration.
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
- STAR-1 topline results expected in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year -- Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -
BloomZ Partners with Badge Inc. to Revolutionize Fan Club Management
BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a leading Japanese anime production, audio production, and voice actor management company, announced a strategic business partnership with Badge Inc. ("Badge"), a Tokyo-based company specializing in online salon and fan club platforms.
LQR House Inc. Secures Liquor Control Board of Ontario (LCBO) Approval for SWOL Tequila in Ontario
First 1,000 Bottles Ordered by Of The Earth Distribution Corp., Marking Key Milestone in Canadian Market Expansion
M2i Global, Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
, a company specializing in the development and execution of a complete global value supply chain for critical minerals, today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.
Rich Products to Celebrate #GivingTuesday with $80,000 in Grants to Food-Related Nonprofits
The initiative pays homage to Rich's impending 80th anniversary
Modular Medical Announces Conference Call to Provide Business Update
Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care.
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to share preclinical data demonstrating the potential of its dual orexin receptor agonist (DOXA) platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to target both orexin-1 (OX1R) and orexin-2 (OX2R) receptors while concurrently inhibiting cathepsins. Cathepsins play significant roles in a variety of physiological processes and may offer a novel therapeutic approach for narcolepsy and other neurological disorders.
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels
InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 03
The Company announces that on 02 December 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Musk $55.8 bn Tesla pay deal again rejected by US judge
A US judge on Monday upheld her decision to reject Elon Musk's massive $55.8 billion compensation package at Tesla, denying an attempt to restore the pay deal through a shareholder vote.
Vietnam property tycoon on death row faces appeal verdict
A Vietnamese property tycoon sentenced to death for a multi-billion-dollar fraud will learn Tuesday whether her life will be spared, as an appeal court reaches its verdict on one of the biggest corruption cases in history.
18 convicted in biggest UK drugs trial
A court has sentenced 18 members of an international crime group behind Britain's "biggest ever detected drugs conspiracy" to up to 32 years in jail after the country's longest-running criminal trial, police said Monday.
Suspect freed from custody over suicide capsule death in Switzerland
A man held since September over the death of a US woman inside a controversial suicide capsule in Switzerland was released from custody Monday, though he remains under suspicion.
Najib says bribery, power abuse charges 'politically motivated'
Malaysia's jailed ex-leader Najib Razak began his defence Monday against graft charges tied to more than $500 million in alleged bribes and several counts of money laundering, saying they were "politically motivated".
'Future of planet' at stake at ICJ hearings: Vanuatu
The future of the planet is at stake during hearings at the top United Nations court, a representative for Vanuatu said Monday, opening a historic case that aims to set a legal framework on how countries should tackle climate change.
30-strong Japan A-bomb delegation to collect Nobel prize
Japanese atomic bomb survivors' group Nihon Hidankyo said Monday a 30-strong delegation will collect its Nobel Peace Prize in Oslo after a crowd-funding campaign to pay their travel costs.
Four decades of horror after India's Bhopal gas disaster
Just after midnight as poisonous plumes of smoke wafted through the Indian city of Bhopal four decades ago, Gas Devi was born, gasping for every breath.
Biden pardons son Hunter in final weeks of presidency
US President Joe Biden on Sunday issued an official pardon for his son Hunter, who is facing sentencing for two criminal cases, despite assurances that he would not intervene in his legal troubles.
NHI Announces Appointment of Candice Todd to the Board of Directors
National Health Investors, Inc. (NYSE:NHI) announced today that Candice Todd will join the NHI Board of Directors effective January 1, 2025.
Allstar Health Brands, Inc. (ALST) Engages in Strategic Acquisition Negotiations with MergersCorp Investment Banking for Italian Soccer Team
All Star Health Brands is pleased to announce that it is entering the final stages of negotiations for the acquisition of a soccer team located in northern Italy, which has most recently competed in Serie D. This team boasts a dedicated stadium and an extensive youth development program, aligning with our strategic objectives to build international partnerships and foster youth engagement in both Canada and the United States.
Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogsCanalevia®-CA1, Jaguar's first-generation antisecretory drug for the treatment of chemotherapy-induced diarrhea in dogs, has received extension of conditional approval by FDA
Must-Visit Attractions in Sun Moon Lake, Taiwan: 2025 Sustainable Travel Recommendations
Sun Moon Lake is in central Taiwan's Yuchi Township of Nantou County. The vast Sun Moon Lake National Scenic Area includes this lake and the surrounding Shuili Township, Puli Town, Xinyi Township, and Jiji Town. This is a year-round tourist destination, with each season offering different experiences. In spring, enjoy hiking and cherry blossoms; in summer, enjoy water sports and fireflies. Bald cypress trees turn red in autumn and winter, and white plum blossoms appear.
Bausch Health Appoints New Chief Medical Officer and Head of R&D
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment of Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D. This strategic addition to our leadership team underscores our commitment to innovation, excellence, and enriching lives.
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has completed mouse model studies providing proof-of-concept for the Company's K1.1 mRNA product as a novel therapeutic agent for human hepatocellular carcinoma.
BOTS Inc. (OTC:BTZI) Announces Strategic Pivot into Autonomous AI Agents on the Solana Blockchain
BOTS Inc. (OTCQB:BTZI), a leader in blockchain and robotics innovation, is excited to unveil its groundbreaking strategic pivot into the development and deployment of autonomous AI agents powered by the Solana blockchain. This bold move reaffirms the company's mission to leverage cutting-edge technologies to drive value creation, enhance operational efficiency, and revolutionize the decentralized artificial intelligence (AI) landscape.
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide
BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 02
Purchase of own shares
Venezuelans protest for release of prisoners held in post-election unrest
Dozens of Venezuelans took to the streets in Caracas on Sunday calling for the release of prisoners detained in protests against the disputed reelection of President Nicolas Maduro.
Social Democrats lead Romania vote, but far right makes big gains
Romania's ruling Social Democrats (PSD) were leading in Sunday's parliamentary elections, but the far right secured big gains, exit polling found, deepening uncertainty in a country rocked by political chaos.